European Cystic Fibrosis Society (ECFS)
Published on European Cystic Fibrosis Society (ECFS) (https://www.ecfs.eu)

Home > Anti-inflammatory effects of lenabasum, a cannabinoid receptor type 2 agonist, on macrophages from cystic fibrosis

Anti-inflammatory effects of lenabasum, a cannabinoid receptor type 2 agonist, on macrophages from cystic fibrosis

Resource Type

CF Research News

Authors

Abdullah A. Tarique , Tama Evron, George Zhang, Mark A. Tepper, Mohammed M. Morshed, Isabella S.G. Andersen, Nelufa Begum, Peter D. Sly, Emmanuelle Fantino

References

J Cyst Fibros. 2020 Sep;19(5):823-829. doi: 10.1016/j.jcf.2020.03.015. Epub 2020 May 6. 

Document

PDF icon CF Research News Article [1]

Link

Scientific Abstract [2]

Keywords

Anti-inflammatory [3]
CB2 agonists [4]
Cannabinoid 2 receptor (CB2) [5]
Endocytosis [6]
Macrophage polarization [7]
Macrophage responses [8]
Phagocytosis [9]

Date

Saturday, September 19, 2020

Featured resource article

Yes

Resource - Guideline Type

Other Guidelines [10]
Terms & Conditions Privacy policy  Accessibility Sitemap Contact 
© EUROPEAN CYSTIC FIBROSIS SOCIETY 2025. All rights reserved. Website by VidaVia (link is external)
European Cystic Fibrosis Society (ECFS)

Source URL:https://www.ecfs.eu/resource-article/cf-research-news/anti-inflammatory-effects-lenabasum-cannabinoid-receptor-type-2

Links
[1] https://www.ecfs.eu/sites/default/files/cf-research-article-files/JCF-D-19-00528R1_FINAL_Sly_111020.pdf [2] https://pubmed.ncbi.nlm.nih.gov/32387042/ [3] https://www.ecfs.eu/research-article-keywords/anti-inflammatory [4] https://www.ecfs.eu/research-article-keywords/cb2-agonists [5] https://www.ecfs.eu/research-article-keywords/cannabinoid-2-receptor-cb2 [6] https://www.ecfs.eu/research-article-keywords/endocytosis [7] https://www.ecfs.eu/research-article-keywords/macrophage-polarization [8] https://www.ecfs.eu/research-article-keywords/macrophage-responses [9] https://www.ecfs.eu/research-article-keywords/phagocytosis [10] https://www.ecfs.eu/resource-guideline-type/other-guidelines